UK Markets closed

Aurora Cannabis Inc. (ACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.01-0.02 (-0.33%)
As of 4:00PM EDT. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Why Aurora Cannabis, Canopy Growth, and Tilray Stock Tumbled Today

    As of 11:05 a.m. EDT, shares of Canopy Growth (NASDAQ: CGC) have fallen 5.8%, Tilray (NASDAQ: TLRY) is down 6%, and Aurora Cannabis (NASDAQ: ACB) is bringing up the rear with a 6.3% decline. The past several days have seen a series of cuts to marijuana stock price targets among Wall Street analysts, you see, in advance of Aurora Cannabis' upcoming fiscal fourth-quarter 2021 earnings report (due out tomorrow). The bad news began back on Thursday, when Roth Capital cut its price target on Tilray in half, to $12 a share, commenting that management's sales projections for fiscal 2024 were too "hopeful" to be true.

  • Motley Fool

    3 Things to Watch For When Aurora Cannabis Reports Earnings This Month

    After the markets close Sept. 21, Aurora Cannabis (NASDAQ: ACB) will release results for its fiscal fourth quarter, which ended June 30. The troubled Canadian pot company's stock is already down by about 20% year to date -- a sharp contrast to the sector benchmark Horizons Marijuana Life Sciences ETF, which is up 5% -- and the upcoming report could be pivotal in determining whether the share price gets out of the red for 2021. Investors aren't expecting to see Aurora turn a profit in the final quarter of its fiscal year, but there are other ways that the company can show it is making progress.

  • Zacks

    Earnings Preview: Aurora Cannabis Inc. (ACB) Q4 Earnings Expected to Decline

    Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.